It varies from province to province, but at this moment we know that every province has had applications to the provincial health ministries for support of the funding necessary to access. But I must point out that at the moment, there are not well-established studies that have gone through the test of rigorous clinical testing. So it is in that early phase at which the patients hear of advances or processes or procedures that are available outside Canada and then undertake to go there.
I think this is going to increase dramatically if we do not support the research and the clinical application infrastructure across the country. I believe we will need before that a rigorous process of testing the utility of these therapies and their cost-effectiveness and the long-term impacts.